Tus kws kho mob
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 16, 2017
Cov Ntaub Ntawv thiab Cov Txiaj Ntsig Ua Tau Los Ntawm Cov Foos
Nthuav pom cov txiaj ntsig tshwm sim 2871 - 2880 ntawm 3820
Tus kws kho mob
P12-17 A New Drug, Pharmaceutical Grade L-Glutamine Will Require Prior Authorization
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 03, 2017
Tus kws kho mob
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P3-17 Added Reimbursement Policies
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 27, 2017
Tus kws kho mob
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 13, 2017
Tus kws kho mob
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017
Tus kws kho mob
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 25, 2017
Tus kws kho mob
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P51-16 Addition of a Drug (Belviq XR) to the Weight Loss Agents Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 28, 2016